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Abstract
Background and Aims: Surgery for Crohn’s disease [CD] can be complicated by an enhanced 
inflammatory response. This retrospective study aims to compare the inflammatory response 
measured by C-reactive protein [CRP] in patients operated for CD with patients undergoing similar 
surgery for colorectal cancer [CRC].
Methods: All CD patients undergoing an ileocaecal resection between February 2001 and December 
2013 were retrieved from a prospectively maintained database. The same number of patients with 
a CRC of the ascending colon, undergoing a laparoscopic right hemicolectomy between March 
2009 and June 2014, were retrieved from a CRC database. CRP level during the first 7 postoperative 
days was used as primary outcome.
Results: Totals of 112 consecutive CD patients (male 40.2%; median age: 32.3 yrs; interquartile 
range [IQR]: 25.2–45.1) and 112 consecutive CRC patients [male 53.6%; median age 71.6 yrs; IQR: 
64.7–77.5] were included. Postoperative CRP level in the CD group was on average 27% higher 
compared with the CRC group [p  = 0.02]. The day-specific differences in CRP values were 21% 
(p = 0.021, 95% confidence interval [CI]: 3% 41%), 41% [p = 0.005, 95% CI: 11% – 79%], 49% [p = 0.007, 
95% CI: 11% – 96%], and 49% [p = 0.006, 95% CI: 12% – 100%] higher for CD patients at Days 1, 4, 
5, and 6 respectively. The difference in postoperative CRP level was partially due to differences in 
preoperative CRP level.
Conclusion: CD patients develop a higher postoperative CRP level, probably reflecting an 
enhanced postoperative inflammatory response, which may be triggered by a higher preoperative 
inflammatory state.
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1. Introduction
CD is an inflammatory bowel disease with a multifactorial patho-
physiology. Genetic, immune, gut microbiota, and other environ-
mental factors play a role in the occurrence and maintenance of 
bowel inflammation. Unfortunately, despite the development of new 
drugs, about half of all CD patients will need surgery during their 
disease course.1
Patients undergoing surgery for CD appear to develop a higher 
inflammatory response in the postoperative phase.2,3 This clinical 
presentation can mimic septic complications in the postoperative 
phase, leading in some cases to either imaging or second-look sur-
gery to rule out an anastomotic leak. CD patients may react dif-
ferently after surgery compared with patients undergoing similar 
surgical procedures for other conditions.
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Most series have focused on postoperative morbidity in terms 
of septic complications including anastomotic leakage and the 
effect of immunomodulatory and biological therapy on surgical 
outcome.4,5,6,7,8,9 However, the postoperative inflammatory response 
as such might also be affected by CD. Therefore, this study aims 
to compare the postoperative inflammatory response between CD 
patients and CRC patients undergoing either a laparoscopic ileocae-
cal resection or a laparoscopic right hemicolectomy, respectively.
2. Materials and Methods
All eligible patients operated for a laparoscopic ileocaecal resection 
for CD between February 2001 and December 2013 were retrieved 
from a prospectively maintained database. The same number of con-
secutive patients with CRC at the ascending colon undergoing a lap-
aroscopic right hemicolectomy between March 2009 and June 2014 
was retrieved from a CRC database. Only patients with elective 
primary laparoscopic [single or multiport] surgery were included, 
in order to minimise the effect of surgical access trauma on postop-
erative inflammatory response. Patients who needed a conversion to 
laparotomy were excluded for the same reason. Patients were evalu-
ated preoperatively by cross-sectional imaging, ileocolonoscopy, or 
both. Patients who presented preoperatively with an intra-abdomi-
nal phlegmone or abscess, and those with documented postoperative 
septic complications, were excluded because of the impact of these 
conditions on postoperative inflammatory response. Septic compli-
cation was defined as the presence of a deep intra-abdominal abscess, 
an anastomotic leak, or the presence of other infectious complica-
tions [catheter sepsis, pneumonia, etc] that could influence the post-
operative CRP level. Patients with CD activity at another location 
were excluded since inflammatory response could be influenced by 
that other site of inflammation. All medical charts were reviewed. 
The following factors were collected in the charts: gender, age at 
diagnosis, age at time of surgery, American Society of Anesthesiology 
[ASA] score, preoperative and postoperative CRP level, preoperative 
and postoperative medication [immunomodulatory, biological or 
antibiotic], and 30-day morbidity. Postoperative CRP was assessed 
daily as part of the routine clinical follow-up in all operated patients 
until discharge. Morbidity was expressed according to the Clavien-
Dindo classification.10 Antibiotics were prescribed at surgeon’s dis-
cretion depending on postoperative clinical assessment.
2.1. Statistics
The primary endpoint was the difference in inflammatory response 
after surgery, expressed as the difference in CRP level during the 
first 7 postoperative days. Fisher’s exact and Mann–Whitney U tests 
were used to compare nominal and ordinal/continuous variables 
between groups, respectively. Relations between ordinal/continuous 
variables were evaluated with Spearman correlations. General linear 
models for longitudinal measures using a direct likelihood approach 
were used to compare the evolution of CRP between both diagnosis 
groups during the first 7 postoperative days. A heterogeneous vari-
ance first-order autocorrelation matrix was used for the covariance 
structure [with robust standard errors correcting for possible mis-
specification of this structure]. Least-squares means and their 95% 
confidence intervals were plotted as a function of time. To obtain 
a symmetrical distribution of the model residuals, the CRP values 
were log-transformed, but results are presented after back-transfor-
mation to the original scale. Note that due to this transformation, 
the exponent of the least-squares mean can be interpreted as a geo-
metrical mean and differences between groups on the log-scales are 
ratios on the original scale. In a first model, only group, time, and 
the interaction were considered as effects. In additional models, the 
comparison between both groups was made after adding potential 
confounders in the model. Considered confounders were age, the 
[log-transformed] baseline level [on the day before surgery], the use 
Table 1. Clinical characteristics of patient population.
CD patients [n = 112] Colorectal cancer patients [n = 112]  p-Value
Gender
Male 45 [40.2%] 60 [53.6%]
Female 67 [59.8%] 52 [46,4%] 0.061
Median age at surgery [IQR] 32.3 [25.2 – 45.1] 71.6 [64.7 – 77.5] < 0.001
Median preoperative CRP level [mg/dl] [IQR] 6.6 [2.8 – 17.8] 2.3 [1.0 – 4.2] < 0.001
ASA score
ASA <= 2 107 [95.5%] 73 [65.2%]
ASA >= 2 5 [4.5%] 39 [34.8%] < 0.001
Preoperative immunomodulating medication 94 [83.9%] - < 0.001
Anti-TNF alpha 42 [37.5%] -
Azathioprine 27 [24.1%] -
Methylprednisolone 16 [14.3%] -
Mesalazine 14 [12.5%] -
Budesonide 13 [11.6%] -
Methotrexate 12 [10.7%] -
Postoperative antibiotic therapy 27/76 [35.5%] 31/112 [27.7%] 0.264
Median postoperative length of hospital stay in days 
[IQR]
7.0 [6.0 – 8.0] 7.0 [6.0 – 9.0] 0.215
Postoperative morbidity score [Clavien-Dindo]
0 93 [83.0%] 98 [87.5%]
1 1 [0.9%] 4 [3.6%]
2 12 [10.7%] 7 [6.3%]
3a 1 [0.9%] 2 [1.8%]
3b 5 [4.5%] - <0.001
IQR, interquartile range; CRP, C-reactive protein; ASA, American Society of Anesthesiology; TNF, tumour necrosis factor; CD, Crohn’s disease.
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of preoperative immunomodulating medication or antibiotics, and 
the use of postoperative antibiotics; p-values smaller than 0.05 were 
considered as significant. All analyses were performed using SAS 
software, version 9.2 of the SAS System for Windows.
3. Results
Totals of 112 CD patients [male 40.2%; median age: 32.3 yrs; IQR: 
25.2 – 45.1] and 112 CRC patients [male 53.6%, median age 71.6 
yrs; IQR: 64.7  – 77.5] were included. Patients’ characteristics are 
summarised in Table 1. CRC patients were significantly older [71.6 
yrs vs 32.2 yrs; p < 0.001], with a higher number of patients with a 
preoperative ASA score of more than 2 [34.8% vs 4.5%; p < 0.001]. 
Although CD patients were numerically taking postoperative anti-
biotics more often compared with CRC patients, this difference was 
not significant [35.5% vs 27.7%; p = 0.264]. The median duration of 
postoperative antibiotic therapy was longer in CD patients [5 days vs 
3 days; p = 0.009]; 83.9% of CD patients were taking some kind of 
immunomodulatory or biological therapy preoperatively. Used drugs 
were mesalazine, azathioprine, methotrexate, methylprednisolone, 
budesonide, and anti-TNF alpha. No CRC patients were prescribed 
such medication [p < 0.001]. Median length of postoperative stay of 
both groups was similar [7 days in both groups; p = 0.215]. Median 
preoperative CRP was significantly lower in CRC patients compared 
with CD patients [23 mg/l vs 66 mg/l; p  <  0.001] and in patients 
without any antibiotics preoperatively compared with patients 
under preoperative antibiotic therapy [24 mg/l vs 62 mg/l; p < 0.001]. 
Preoperative CRP was not influenced by either ASA score [p = 0.066] 
or gender [p = 0.240]. Patients’ characteristics are listed in Table 1.
Postoperative CRP level in the CD group was on average 27% 
higher compared with the CRC group [p = 0.02]. The day-specific 
differences in CRP values were 21% [p  =  0.021, 95% CI: 3% – 
41%] higher in CD patients at Day 1, 41% [p = 0.005, 95% CI: 11% 
- 79%] at Day 4, 49% [p = 0.007, 95% CI: 11% – 96%] at Day 5 
and 49% [p = 0.006, 95% CI: 12% - 100%] at Day 6 [Figure 1]. The 
magnitude of the difference between both groups remained similar 
after correction for age and preoperative and postoperative intake 
of antibiotics or immunomodulators. However, after correction for 
preoperative CRP level, the difference in average postoperative CRP 
level reduced to 14% [p  =  0.23] in the CD group, and remained 
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Figure 1. Postoperative (geometric) mean CRP-level with 95% confidence interval (CI) without correcting for potential confounders. Geometric mean and CI are 
obtained after backtransforming the results from the general linear model on the log-transformed CRP-values to the original scale. Postoperative days with a 
significant difference in CRP-level are indicated with * (p<0.05).
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Figure 2. Postoperative (geometric) mean CRP-level with 95% confidence interval (CI), after correcting for preoperative CRP level. Geometric mean and CI are 
obtained after backtransforming the results from the general linear model on the log-transformed CRP-values to the original scale. Postoperative days with a 
significant difference in CRP-level are indicated with * (p<0.05). 
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significant at Day 6 only [39% higher CRP in CD group, p = 0.036] 
[Figure  2]. Even after correction for age, pre- and postoperative 
intake of antibiotics or immunomodulators, and preoperative CRP 
level, the postoperative CRP level remained significantly higher in 
the CD group at Day 6 [64%, p = 0.035]. Multivariate regression 
analysis is represented in Table 2.
4. Discussion
Our series of 224 patients showed a significantly increased inflamma-
tory response in patients operated for CD, compared with patients 
undergoing the same operation for CRC. CRP was significantly 
higher on postoperative Days 1, 4, 5, and 6. The magnitude of the 
average difference decreased and statistical significance disappeared 
on Days 1, 4, and 5 when correcting for preoperative CRP, suggest-
ing that the baseline state of inflammation in part contributes to the 
postoperative response. The occurrence of an enhanced postopera-
tive inflammatory response has been confirmed in other series.2,3,11
The origin of this observation may be multifactorial. Bacterial 
translocation to mesenteric lymph nodes is often present in 
CD.2,3 This is probably facilitated by an impaired mucosal bar-
rier, caused by mucus alteration, damaged tight junctions, and 
areas of cell loss at villous tips.12 Moreover, CD patients develop 
intestinal bacterial overgrowth by delayed transit time or the 
presence of fistulas.13,14 The combination of an altered mucosal 
layer with bacterial overgrowth probably facilitates bacterial 
translocation.
A defect in innate immunity has been described in CD patients, 
reflected by a decreased accumulation of neutrophils and interleukin 
8 in intestinal mucosa and the skin.15,16 Intrinsic properties in terms 
of transepithelial migration and impaired cellular signalling of neu-
trophils seem to be changed.17 This defect in innate immunity could 
have an impact on the clearance of translocated bacteria, leading to 
higher inflammatory response.
Bacterial translocation has been identified as a risk factor 
for both postoperative inflammatory response and morbidity.3,18 
Translocated bacteria induce a cytokine response, which might 
explain the increased postoperative inflammatory response.19,20 
Morbidity in terms of septic complications and postoperative fever 
in patients with bacterial translocation have been reported by some 
studies, often without being able to isolate any bacterial agent in 
blood cultures.3,21 Further research should probably focus on the 
impact of improved perioperative antibiotic prophylaxis on surgical 
complication rates in CD patients.
This study is limited by its retrospective design. However, the 
use of a biological parameter renders this retrospective study more 
robust, by relying on objective measures. Furthermore, the low speci-
ficity of CRP has been bypassed by selecting patients without any 
septic complications and with the same minimally invasive access, 
to obtain a homogeneous population. Another limitation is the dif-
ference in age between the patients with CD and CRC. The CRP 
response is somewhat blunted at older age but, on the other hand, 
adjusting for age did not influence our results.22 We believe therefore 
that CRP is a good biomarker for the impact of surgery on patients’ 
postoperative inflammatory response.
Postoperative inflammatory response is higher in CD patients 
compared with CRC patients, probably rendering the postoperative 
diagnosis of any septic complications in those patients more deli-
cate. This may lead to an increased rate of unnecessary postopera-
tive medical imaging or second-look surgery. A better prophylactic 
antibiotic use may eventually attenuate inflammatory response in 
CD patients.
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